Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ovid Therapeutics Inc (NQ: OVID ) 1.090 -0.010 (-0.91%) Streaming Delayed Price Updated: 11:51 AM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ovid Therapeutics Inc < Previous 1 2 3 Next > New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications April 12, 2023 New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this... Via Benzinga Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead April 11, 2023 In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating... Via Benzinga Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension April 11, 2023 Via Benzinga Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference April 10, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Looking Into Ovid Therapeutics's Return On Capital Employed March 15, 2023 Via Benzinga Ovid Therapeutics: Q1 Earnings Insights May 10, 2022 Ovid Therapeutics (NASDAQ:OVID) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results March 13, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum March 09, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures March 08, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference February 28, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments February 08, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial January 05, 2023 A Potential, Next-Generation GABA-Aminotransferase Inhibitor for Rare Epilepsies with Limited Treatment Options From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022) December 02, 2022 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights November 08, 2022 From Ovid Therapeutics Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday May 26, 2022 On Thursday, 94 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Monday May 23, 2022 On Monday, 149 companies reached new 52-week lows. Via Benzinga 3 Biotech Stocks Under $10 to Add to Your Buy List April 26, 2022 These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk. Via InvestorPlace Overview Of Value Stocks In The Healthcare Sector April 11, 2022 Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... Via Benzinga Overview Of Value Stocks In The Healthcare Sector February 21, 2022 What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 27, 2022 Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday January 27, 2022 Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday! Via InvestorPlace Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact January 03, 2022 Ovid Therapeutics Inc (NASDAQ: OVID) has entered into an exclusive license agreement with AstraZeneca plc (NASDAQ: AZN) for a library of early-stage small... Via Benzinga 5 Value Stocks In The Healthcare Sector December 27, 2021 Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... Via Benzinga A Look Into Healthcare Sector Value Stocks September 13, 2021 What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... Via Benzinga The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO July 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 08, 2021 Gainers Aytu BioPharma (NASDAQ:AYTU) stock increased by 19.36% to $6.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $161.3... Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector May 24, 2021 What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 13, 2021 Gainers Bionano Genomics (NASDAQ:BNGO) st... Via Benzinga Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions April 19, 2021 Ovid Therapeutics Inc (NASDAQ: OVID) has announced to discontinue the development of OV101 (gaboxadol), a delta (δ)-selective GABAA receptor agonist, in... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021 April 20, 2021 Upgrades Compass Point upgraded the previous rating for Newtek Business Services Corp (NASDAQ:NEWT) from Neutral to Buy. For the fourth quarter, Newtek Business Services... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.